Skip to content

Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness

Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00661869
Acronym
Wellness
Enrollment
295
Registered
2008-04-21
Start date
2006-09-30
Completion date
2008-01-31
Last updated
2010-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia, Schizoaffective Disorder, Bipolar Disorder

Brief summary

Obesity is increasing at an alarming rate in patients with schizophrenia, possibly in association with the increased use of atypical antipsychotics. In order to address the weight and metabolic syndrome issues, Manhattan Psychiatric Center (MPC) has implemented the Solutions for Wellness and Team Solutions Program. This program is designed to create a supportive, educational and monitoring environment to stabilize both the psychiatric and medical conditions and to prepare patients for independent management of their psychiatric and physical health condition in the community.

Detailed description

The present program is divided into five detailed segments with three progressive levels, that provide a manualized lesson-by-lesson curriculum for implementation on the treatment mall. * Medication Education * Symptom recognition and management * Living Healthy * Interpersonal Skills * Discharge Preparation The program comprised of detailed instructor and patient manuals, specific curriculums and pre- and post-tests to determine acquisition of the learned materials. All modules are imbedded in weekly small group sessions. * Each of the 5 modules are discussed in groups in weekly morning or afternoon session, Monday through Friday. * Each module is divided into three 12-week periods for a total of 36 sessions. * Upon completing 12 weeks at Level 1, each patient moves to Level 2 and then Level 3 for 12 weeks each. * Each group has two trained instructors. * Number of patients per group: ≤ 15. * Sessions are interspersed within the patient's regular treatment mall classes

Interventions

36 weeks of educational and supportive interventions

Sponsors

Eli Lilly and Company
CollaboratorINDUSTRY
Manhattan Psychiatric Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Are at lease 18 years of age; ≤ 65 years. 2. Are male or female 3. Are currently hospitalized at Manhattan Psychiatric Center and attend daily treatment mall programs. 4. Are fluent in the language of the investigator, and study staff (including testing administrators, group leaders and supervisors) 5. Have a documented current psychiatric diagnosis as obtained from patient's medical charts and recorded by a qualified psychiatrist. 6. Recently admitted patients will be included if their clinical state permits it.

Exclusion criteria

1. Are \> 65 years of age; 2. Are currently enrolled in the Intensive Psychiatric Services (IPS) program at Manhattan Psychiatric Center;

Design outcomes

Primary

MeasureTime frame
Pre and post-test knowledge assessments attained from each module36 weeks
Change in weight, abdominal girth, blood pressure, metabolic markers (Glucose , Insulin, C-peptide, Glycohemoglobin, total cholesterol, total triglycerides, HDL and LDL, leptin, and free fatty acid (FFA))36 weeks

Secondary

MeasureTime frame
Systolic and diastolic blood pressure36 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026